Vitacost faces dissident shareholder
This article was originally published in The Tan Sheet
Executive SummaryBoca Raton, Fla.-based Vitacost.com hires a financial advisor to help it identify "potential business combination partners and purchaser candidates." The May 20 announcement came five days before Vitacost's largest shareholder, Great Hill Equity Parnters, proposed four nominees to replace current board members. The shareholder explained the online dietary supplement retailer has experienced "significant erosion in stockholder value" since its 2009 initial public offering, according to a release. Great Hill attributes Vitacost's flat sales growth, high turnover and troubled manufacturing and logistics to "a board comprised of directors with little, if any, public company or Internet, eCommerce or direct marketing experience.
You may also be interested in...
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.